Twist Bioscience Corporation (TWST) Operating cash flow 2017–2025
Twist Bioscience Corporation (TWST) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$47.6MFY2025 · since FY2017: -$51.3M → -$47.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$47.6M | +25.7% |
| FY2024 | -$64.1M | +55.0% |
| FY2023 | -$142.5M | -14.5% |
| FY2022 | -$124.4M | -10.8% |
| FY2021 | -$112.2M | +21.1% |
| FY2020 | -$142.3M | -61.8% |
| FY2019 | -$87.9M | -32.9% |
| FY2018 | -$66.2M | -29.0% |
| FY2017 | -$51.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TWST financial trends
TWST RevenueTWST Net incomeTWST Net marginTWST Gross profitTWST Gross marginTWST Operating incomeTWST Operating marginTWST Free cash flowTWST Capital expendituresTWST Return on equityTWST Stock buybacksTWST Dividends paidTWST Total assetsTWST Total liabilitiesTWST Shareholders’ equityTWST overview →